Abstract
Purpose
Traumatic brain injury (TBI) is one of the most common causes of death among trauma patients. Earlier prediction of possible poor neurological outcomes, even upon admission to the emergency department, may help to guide treatment. The aim of this prospective study was to assess the predictive value of plasma copeptin levels for early morbidity and mortality in patients with isolated TBI.
Methods
This prospective study comprised 53 patients who were admitted to the emergency department with isolated TBI. Forty-two of these patients (group I) survived at least 1 month after the TBI; the other 11 (group II) did not. Plasma levels of copeptin were measured in these TBI patients at admission and 6 h after trauma, and were compared with those of healthy volunteers (group III).
Results
At admission, the copeptin levels of the TBI patients (groups I and II combined) were not statistically significantly different from those of the control group (III). The copeptin levels 6 h after trauma were also not statistically significantly different from those at admission. Δ-Copeptin levels (the difference between the copeptin level at the 6th hour after trauma and that at admission) were higher in the patients who died within a month of the TBI. Further, Δ-copeptin levels were higher in patients who showed no improvement in the modified Rankin score when compared with patients with an improved modified Rankin score. The best cutoff point for Δ-copeptin was 0.51 ng/ml for predicting mortality and 0.23 ng/ml for predicting improvement in the modified Rankin score.
Conclusions
Plasma Δ-copeptin levels may help physicians predict the prognoses of patients suffering from traumatic brain injury.
Similar content being viewed by others
References
Shigemori M, Abe T, Aruga T, Ogawa T, Okudera H, Ono J, et al. Guidelines for the management of severe head injury, 2nd edn: guidelines from the Guidelines Committee on the Management of Severe Head Injury, the Japan Society of Neurotraumatology. Neurol Med Chir (Tokyo). 2012;52:1–30.
Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J Neurotrauma. 2007;24:S37–44.
Morgenthaler NG, Struck J, Jochberger S, Dünser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab. 2008;19:43–9.
Kleindienst A, Brabant G, Morgenthaler NG, Dixit KC, Parsch H, Buchfelder M. Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity. Acta Neurochir Suppl. 2010;106:221–4.
Dong XQ, Huang M, Yang SB, Yu WH, Zhang ZY. Copeptin is associated with mortality in patients with traumatic brain injury. J Trauma. 2011;71:1194–8.
Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, Mueller B, Christ-Crain M. Copeptin is associated with mortality and outcome in patients with acute intracerebral haemorrhage. BMC Neurol. 2010;10:34.
Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Müller K, Meckel S, Gass A, Kappos L, Steck AJ, Engelter ST, Müller B, Christ-Crain M. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol. 2009;66:799–808.
Nickel CH, Bingisser R, Morgenthaler NG. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med. 2012;10:7.
Westermann I, Dünser MW, Haas T, Jochberger S, Luckner G, Mayr VD, Wenzel V, Stadlbauer KH, Innerhofer P, Morgenthaler N, Hasibeder WR, Voelckel WG. Endogenous vasopressin and copeptin response in multiple trauma patients. Shock. 2007;28:644–9.
Stoiser B, Mortl D, Hulsmann M, Berger R, Struck J, Morgenthaler NG, Bergmann A, Pacher R. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest. 2006;36:771–8.
Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock. 2007;28:219–26.
Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, Müller C, Struck J, Müller B, Tamm M. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest. 2007;131:1058–67.
De Marchis GM, Katan M, Weck A, Brekenfeld C, Mattle HP, Buhl D, Müller B, Christ-Crain M, Arnold M. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk Study. Int J Stroke. 2013;8:214–8.
Lotze U, Lemm H, Heyer A, Müller K. Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital. Vasc Health Risk Manag. 2011;7:509–15.
Zhang A, Li J, Li X, Song L, Li H. The prognostic value of copeptin for acute intracerebral haemorrhage patients. Exp Ther Med. 2013;5:467–70.
Molnar AH, Varga C, Berko A, Rojik I, Párducz A, László F, László FA. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced byglobal cerebral ischaemia. Acta Neurochir. 2008;150:265–71.
Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S, Padilla-Martínez JJ, González-Cornejo S. Grading scale for prediction of outcome in primary intracerebral haemorrhages. Stroke. 2007;38:1641–4.
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral haemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.
Ono J, Yamaura A, Kubota M, Okimura Y, Isobe K. Outcome prediction in severe head injury: analyses of clinical prognostic factors. J Clin Neurosci. 2001;8:120–3.
Roe C, Skandsen T, Anke A, Ader T, Vik A, Lund SB, Mannskow U, Sollid S, Sundstrøm T, Hestnes M, Andelic N. Severe traumatic brain injury in Norway: impact of age on outcome. J Rehabil Med. 2013;45:734–40.
Barlas O, Karadereler S, Krespi Y, Yesilot N, Bahar S, Tuncay R, Tolun R. Decompressive hemicraniectomy in patients with transtentorial herniation. Sinir Sistemi Cerrahisi Derg. 2008;1:161–8.
Çavuşoğlu H, Kaya RA, Türkmenoğlu ON, Aydin Y. Value of early unilateral decompressive craniectomy in patients with severe traumatic brain injury. Ulus Travma Acil Cerrahi Derg. 2010;16:119–24.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cavus, U.Y., Yildirim, S., Gurer, B. et al. The prognostic value of plasma Δ-copeptin levels in patients with isolated traumatic brain injury. Eur J Trauma Emerg Surg 40, 373–378 (2014). https://doi.org/10.1007/s00068-013-0357-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00068-013-0357-4